HepatoChem
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
The leading innovator and manufacturer of photoreactors, metabolites and LEDs since 2008
Innovative Technology Platform HepatoChem specializes in the development and manufacturing of photoreactors, metabolites, and LEDs, leveraging a proven technology platform built through partnerships with academic institutions like Princeton University. This positions the company as a potential partner for firms seeking advanced photochemistry or LED solutions.
Growth and Revenue With estimated revenues between 10 million and 25 million dollars, HepatoChem demonstrates solid market presence in the pharmaceutical manufacturing industry, indicating opportunities for suppliers of raw materials, equipment, or complementary technologies.
Recent Collaborations The company's partnership with Princeton International highlights an openness to collaborations and research-driven development, which could open doors for joint ventures, research grants, or technology licensing opportunities.
Niche Market Focus Operating with a small team of 2-10 employees, HepatoChem maintains a focused approach in a specialized market segment, making targeted outreach to niche suppliers, custom chemical manufacturers, or scientific equipment providers more effective.
Competitive Positioning As a leader in photoreactors and related technologies with a unique academic partnership, HepatoChem offers a distinctive value proposition for suppliers of specialized equipment, research reagents, or advanced manufacturing solutions tailored to life sciences.
HepatoChem uses 8 technology products and services including DoubleClick Floodlight, Cloudflare, Google Fonts API, and more. Explore HepatoChem's tech stack below.
| HepatoChem Email Formats | Percentage |
| First.Last@hepatochem.com | 100% |
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
The leading innovator and manufacturer of photoreactors, metabolites and LEDs since 2008
HepatoChem has raised a total of $330K of funding over 2 rounds. Their latest funding round was raised on Apr 30, 2012 in the amount of $330K.
HepatoChem's revenue is estimated to be in the range of $10M$25M
HepatoChem has raised a total of $330K of funding over 2 rounds. Their latest funding round was raised on Apr 30, 2012 in the amount of $330K.
HepatoChem's revenue is estimated to be in the range of $10M$25M